Indeed, a report by the group of Mauri et al. provided evidence that experimental therapy with an agonistic Ab against CD40 can ameliorate autoimmune disease [61], as did cellular therapy with Breg cells [50], although a combined treatment was not yet tested. The gene discussed is CD40; the disease is autoimmune disease.